These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 4356685)

  • 1. Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus.
    Hartmann K; Wooding A; Bergmann M
    Vet Sci; 2015 Dec; 2(4):456-476. PubMed ID: 29061953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.
    Brod SA
    Pharmaceuticals (Basel); 2010 Apr; 3(4):1108-1121. PubMed ID: 27713291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oromucosal Administration of Interferon to Humans.
    Beilharz MW; Cummins MJ; Bennett AL; Cummins JM
    Pharmaceuticals (Basel); 2010 Jan; 3(2):323-344. PubMed ID: 27713254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of enteral absorption of human interferon alpha and selective transfer into lymphatics in rats.
    Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S
    Pharm Res; 1985 Sep; 2(5):249-50. PubMed ID: 24272847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Interferon Suppositories. I. Enhanced Rectal Absorption of Human Fibroblast Interferon by Fusogenic Lipid via Lymphotropic Delivery in Rats.
    Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S
    Pharm Res; 1986 Apr; 3(2):116-7. PubMed ID: 24271471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline infectious peritonitis.
    Hartmann K
    Vet Clin North Am Small Anim Pract; 2005 Jan; 35(1):39-79, vi. PubMed ID: 15627627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte interferon: separation of biologically different species by modification of carbohydrate moieties.
    Salit MG; Ogburn CA
    Arch Virol; 1980; 63(2):133-42. PubMed ID: 6243919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effects of interferon on a somatic cell hybrid between two Burkitt's lymphoma cell lines of different interferon sensitivities.
    Lidin B; Lamon EW
    Infect Immun; 1982 May; 36(2):847-9. PubMed ID: 6177642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon therapy: pharmacokinetic and pharmacological aspects.
    Billiau A
    Arch Virol; 1981; 67(2):121-33. PubMed ID: 6163417
    [No Abstract]   [Full Text] [Related]  

  • 10. RNase activity in human interferon preparations.
    Winchurch RA; Karpetsky TP; Levy CC; Cantell K
    J Virol; 1977 Mar; 21(3):1247-8. PubMed ID: 850310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sialic acid in determining the survival of circulating interferon.
    Bocci V; Pacini A; Pessina GP; Bargigli V; Russi M
    Experientia; 1977 Feb; 33(2):164-6. PubMed ID: 844537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of human lymphoblastoid interferon.
    Strander H; Mogensen KE; Cantell K
    J Clin Microbiol; 1975 Jan; 1(1):116-7. PubMed ID: 170301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple active sites on human interferons.
    Paucker K; Dalton BJ; Ogburn CA; Törmä E
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4587-91. PubMed ID: 53841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon clearance rate decreased after repeated injections.
    Nuwer MR; De Clercq E; Merigan TC
    J Gen Virol; 1971 Aug; 12(2):191-4. PubMed ID: 4330791
    [No Abstract]   [Full Text] [Related]  

  • 16. The kinetics of human interferon clearance in gibbons.
    Skreko F; Zajac I; Bahnsen HP; Haff RF; Cantell K
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):946-7. PubMed ID: 4692028
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of routes of administration of interferon in cancer: a review and a proposal.
    Bocci V
    Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte interferon: production, purification, stability, and animal experiments.
    Cantell K; Hirvonen S; Mogensen KE; Pyhälä L
    In Vitro Monogr; 1974; (3):35-8. PubMed ID: 4620359
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.